Sweep gas nitric oxide (sNO) is emerging as an adjunctive therapy, which may have positive impacts on thrombosis and inflammation during ECMO treatment. sNO is administered to the gas phase of the ECMO oxygenator with the aim of reducing contact activation of blood when flowing through and over artificial surfaces. NO delivery devices have gas flow requirements that are above the sweep gases requirements of smaller patients supported on ECMO. To facilitate sNO delivery in patients requiring a sweep flow rate below the required bias flow rate of NO delivery devices, varying sNO delivery setups have been described. Here, we describe three systems for safe and reliable sNO delivery.
HatamiSHeflerJFreedDH. Inflammation and oxidative stress in the context of extracorporeal cardiac and pulmonary support. Front Immunol2022; 13: 831930.
2.
ChilettiRFincherSHHortonSB, et al.The role of nitric oxide in the sweep gas for patients receiving extracorporeal membrane oxygenation or cardiopulmonary bypass. Can J Cardiol2025; 41: 621–629.
3.
JamesCMillarJHortonS, et al.Nitric oxide administration during paediatric cardiopulmonary bypass: a randomised controlled trial. Intensive Care Med2016; 42: 1744–1752.
4.
MillarJEFanningJPMcDonaldCI, et al.The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology. Crit Care2016; 20: 387.
5.
O'MearaCTimpaJPeekG, et al.Nitric oxide on extracorporeal life support-circuit modifications for a safe therapy. J Extra Corpor Technol2022; 54: 142–147.
6.
PanKCNamachivayamSPChilettiR, et al.Clinical effects of nitric oxide added to the oxygenator of children on extracorporeal membrane oxygenation: pre-post cohort study. ASAIO J2024; 70: 698–703.
7.
GianniSCarrollRWKacmarekRM, et al.Inhaled nitric oxide delivery systems for mechanically ventilated and nonintubated patients: a review. Respir Care2021; 66: 1021–1028.
8.
BrinkleyLBrockMAStinsonG, et al.The biological role and future therapeutic uses of nitric oxide in extracorporeal membrane oxygenation, a narrative review. Perfusion2025; 40: 83–91.
9.
BrockMAEbraheemMJaudonA, et al.The safe addition of nitric oxide to the sweep gas of the extracorporeal membrane oxygenation circuit in a pediatric cardiac intensive care unit. Perfusion2025; 40: 490–494.
10.
MattkeACJohnsonKGibbonsK, et al.Nitric oxide on extracorporeal membrane oxygenation in neonates and children (NECTAR trial): protocol for a randomized controlled trial. JMIR Res Protoc2023; 12: e43760.
BreuerJWaidelichFIrtel von BrenndorffC, et al.Technical considerations for inhaled nitric oxide therapy: time response to nitric oxide dosing changes and formation of nitrogen dioxide. Eur J Pediatr1997; 156: 460–462.
19.
ThomsonRMBurkeAJMorganLC, et al.A pilot study to assess the effect of intermittent inhaled nitric oxide as treatment of nontuberculous mycobacteria lung infection. Ann Am Thorac Soc2025; 19(2): 20250408.
20.
ChilettiRHortonSBednarzA, et al.Safety of nitric oxide added to the ECMO circuit: a pilot study in children. Perfusion2018; 33: 74–76.
21.
CavayasYAMunshiLDel SorboL, et al.The early change in Pa(CO(2)) after extracorporeal membrane oxygenation initiation is associated with neurological complications. Am J Respir Crit Care Med2020; 201: 1525–1535.
